FDANonrulemakingFDA-2017-D-6526

DSCSA Grandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier

RIN

—

Last modified

Sep 20, 2018

Comment window

closed 3105d ago

Association for Accessible Medicines filings

Activity

Association for Accessible Medicines filed 1 comment on this docket between Jan 26, 2018 and Jan 26, 2018. 5 other organizations filed here. The comment window closed 3105d ago.

What Association for Accessible Medicines filed (1)

Jan 26, 2018· Comment from Association for Accessible Medicines· FDA-2017-D-6526-0006

Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding FDA-2017-D-6526 DSCSA Grandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (5)

See everyone who commented →

Association for Accessible MedicinesTHIS ORG
1 filing · confidence 97%
Healthcare Distribution Alliancetrade assoc.
2 filings · confidence 85%
American Pharmacists Association (APhA)trade assoc.
1 filing · confidence 97%
Apotex Corpunverified attribution
1 filing · confidence 70%
Health Industry Distributors Associationtrade assoc.
1 filing · confidence 85%
Pharmaceutical Distribution Security Alliancetrade assoc.
1 filing · confidence 85%